|
Post by CM kipper007 on Jul 26, 2014 16:44:53 GMT
|
|
|
Post by dayanand33 on Jul 26, 2014 18:37:41 GMT
I do concede to the argument that CIRM bestowed favors to Stem Cell Inc because of the company's connections within CIRM. However, I would not tie this to CEO selling his shares. He sold it just before releasing the amd efficacy results. Most R&D small cap cos are strapped of money and arrange for financing after releasing positive news. This is exactly what STEM did. I don't see anything wrong in CEO's actions as far as selling his stocks are concerned. This is not GR 27.
|
|
|
Post by Keybridge - Cult Member 003 on Jul 27, 2014 0:15:51 GMT
My guess is that CIRM's decisions are just riddled with cronyism, political and otherwise. I suspect the real reason why ACT never received CIRM funding was that it was blocked by certain insiders - and I suspect that West may have been part of that. It will be interesting to see whether this investigation dies out or evolves into something much broader (and serious). I'm a little bit surprised that the STEM financing actually closed given the latest revelations. Pretty foolish to agree to follow through on the financing when allegations about quality control issues and conflicts of interest are made public.
|
|
|
Post by CM kipper007 on Jul 27, 2014 1:46:49 GMT
Yeah, it possible, but I also think it's possible he sold then thinking there could be a big tank in share price later and selling then would be less suspicious. I do concede to the argument that CIRM bestowed favors to Stem Cell Inc because of the company's connections within CIRM. However, I would not tie this to CEO selling his shares. He sold it just before releasing the amd efficacy results. Most R&D small cap cos are strapped of money and arrange for financing after releasing positive news. This is exactly what STEM did. I don't see anything wrong in CEO's actions as far as selling his stocks are concerned. This is not GR 27.
|
|